ArticleTranslational lung cancer research2019

CheckMate 153 study: are age and performance status relevant for immune checkpoint inhibitor efficacy?

Jose Carlos Benitez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.